Table 3.
Antimicrobial Susceptibility Pattern of 37 Bacterial Isolates Among 300 Participants Living with HIV Attending CTC Clinic at KCMC from July to September 2020
| Isolated Bacteria | Gen | Pip | Ceft | Amoxc | Amik | Clin | Nitr | Chlor | Vanc | TX | Cipro | Cefo | Pen | Ery |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Gram negative (n = 12) | ||||||||||||||
| E. coli (n=6) | NA | NA | NA | NA | NA | |||||||||
| Sensitive | 2 (50) | 5 (100) | 6 (100.0) | 1 (100) | 3 (100 | 4 (66.7) | 4 (66.7) | |||||||
| Resistant | 2 (50) | 0(0) | 0(0) | 0(0) | 0(0) | 2 (33.3) | 2 (33.3) | |||||||
| Citrobacter spp. (n=4) | NA | NA | NA | NA | ||||||||||
| Sensitive | 4 (100.0) | 1 (33.3) | 4 (100.0) | 4 (100.0) | 3 (100) | 1 (25.0) | 1 (100) | 1 (33.3) | ||||||
| Resistant | 0(0) | 2 (66.7) | 0(0) | 0(0) | 0(0) | 3 (75.0) | 2 (66.7) | 2 (100) | ||||||
| Klebsiella (n=2) | NA | NA | NA | NA | ||||||||||
| Sensitive | 2 (100.0) | 1 (50.0) | 2 (100.0) | 2(100) | 2 (100.0) | |||||||||
| Resistant | 0(0) | 1 (50.0) | 0(0) | 0(0) | 1 (100) | 0(0) | 1 (100) | |||||||
| Total n(%) | ||||||||||||||
| S | 8(80) | 1(33.3) | 10(90.9) | 12(100) | 4(100) | NA | 6(66.7) | 1(100) | NA | 5(50) | 6(60) | NA | 1(100) | NA |
| R | 2(20) | 2(66.7) | 1(9.1) | 0(0) | 0(0) | NA | 3(33.3) | 0(0) | NA | 5(50) | 4(40) | NA | 0(0) | NA |
| Gram positive (n = 25) | ||||||||||||||
| S. aureus (n=11) | NA | NA | NA | |||||||||||
| Sensitive | 5 (100) | 4 (44.4 | 1 (16.7) | 6 (100) | 6 (54.5) | 3 (50) | 1 (50) | 2 (22.2) | ||||||
| Intermediate | 0(0) | 0(0) | 1 (16.7) | 1 (9.1) | ||||||||||
| Resistant | 0(0) | 5 (55.6) | 4 (66.7) | 1 (100) | 3 (27.3) | 3 (100) | 3 (50) | 1 (50) | 4 (100) | 7 (77.8) | ||||
| Streptococcus spp. (n=2) | NA | NA | NA | NA | NA | |||||||||
| Sensitive | 1 (100) | 1 (50.0) | 1 (100) | |||||||||||
| Intermediate | 1 (100) | |||||||||||||
| Resistant | 1 (50.0) | |||||||||||||
| Enterococcus spp. (n=12) | NA | |||||||||||||
| Sensitive | 3 (42.9) | 4 (66.7) | 1 (100) | 9 (81.8) | 4 (100) | 9 (75.0) | 1 (8.3) | 6 (54.5) | 3 (30) | |||||
| Intermediate | 1 (14.3 | 1 (100) | 1 (9.1) | 1 (8.3) | 2 (20) | |||||||||
| Resistant | 3 (42.9) | 2 (33.3) | 1 (100) | 1 (9.1) | 2 (16.7) | 2 (16.7) | 11 (91.7) | 1 (100) | 5 (45.5) | 5 (50) | ||||
| Total n(%) | NA | |||||||||||||
| S | 9(69.2) | 8(53.3) | 1(100) | 1(14.3) | 15(88.) | 4(80) | 15(68.2) | 1(14.3) | 4(22.2) | 1(33.3) | 6(37.5) | 6(30) | ||
| I | 1(7.7) | 0(0) | 0(0) | 1(14.3) | 1(5.9) | 0(0) | 2(9.1) | 0(0) | 0(0) | 0(0) | 1(6.3) | 2(10) | ||
| R | 3(23.1) | 7(46.7) | 0(0) | 5(71.4) | 1(5.9) | 1(20) | 5(22.7) | 6(85.7) | 14(77.8) | 2(66.7) | 9(56.2) | 12(60) |
Abbreviations: Gen, gentamycin; Pip, piperacillin; Ceft, ceftriaxone; amoxc, amoxicillin-clavulanic acid; amik, amikacin; clind, clindamycin; Nitr, nitrofurantoin; chlor, chloramphenicol; vanc, vancomycin; TX, trimethoprim-sulfamethoxazole; cipro, ciprofloxacin; cefo, cefotaxime; pen, penicillin; ery, erythromycin.